ABBV Stock AbbVie Inc - Complete Overview

Nyse / Pharmaceutical Products / Healthcare / ABBV Stock

AbbVie Inc (ABBV) price per share as of 22 Jun 2018
USD
Your sentiment
COLDTRENDOMETERHOT
Shares Outstanding 1.59B
Avg Daily Volume 8.96M
Market Cap 158.96B
Volatility 32.20% MEDIUM

ABBVIE INC (ABBV) OVERVIEW

ABBV stock is a pharmaceutical products company traded on Nyse. It is valued at 158.96B US dollars. There are 1.59B shares outstanding which AbbVie Inc issued to investors. Volatility of the stock is MEDIUM, and the daily volume is 32.20% stock on average. AbbVie Inc is paying dividends with the latest yield of 2.90%. It brought investors a total return of 33.66% over the last 12 months. AbbVie Inc stock is reasonably priced. It's P/E ratio is near the market average.

AbbVie Inc (ABBV) STOCK PRICE PERFORMANCE

ABBV SHAREHOLDER'S RETURN

Earnings Per Share 3.99
Dividends Per Share 2.95
12 Months Price Performance High
Dividend Yield Low
Total Return High

ABBV LATEST NEWS

Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks

J&J's dividend is good. But these are even better.

AbbVie: Forget Humira Concerns And Hold On To This Pharma Giant

AbbVie Inc. was spun-off from Abbott in 2013 and is one of the largest pharma players within the oncology and immunology space.The upcoming patent expiry of Humira, its largest selling drug coupled wi

Better Buy: AbbVie Inc. vs. GlaxoSmithKline plc

Which big pharma stock wins in a head-to-head comparison?

Humira's Sales Will Decline -- and It's Fantastic News for AbbVie

Even with falling sales, Humira should still rank as the top-selling drug in the world in 2024.

Abbvie/Roche's Leukemia Drugs Combination Gets FDA Approval

AbbVie (ABBV) and Roche's (RHHBY) cancer drugs, Venclexta and Rituxan receive approval for combination use in second-line chronic lymphocytic leukemia.

3 Reasons to Expect Smooth Sailing for AbbVie's Mission-Critical Candidate

Everything's falling into place for AbbVie's next arthritis drug.

AbbVie Inc (ABBV) TECHNICAL INDICATORS

Name Value Action
RSI(14) 33.12 Sell
CMO(14) -33.76 Strong sell
ADX(14) 19.26 N/A
Williams %R -99.22 Overbought

ABBV FORUM DISCUSSIONS